<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE pdf2xml SYSTEM "pdf2xml.dtd">

<pdf2xml>
<page number="1" position="absolute" top="0" left="0" height="792" width="612">
	<fontspec id="0" size="22" family="Times" color="#000000"/>
	<fontspec id="1" size="8" family="Times" color="#000000"/>
	<fontspec id="2" size="7" family="Times" color="#000000"/>
<text top="23" left="55" width="517" height="33" font="0"><b>ENCODE DCC Antibody Validation Document</b></text>
<text top="77" left="48" width="81" height="12" font="1">Date of Submission</text>
<text top="347" left="39" width="41" height="12" font="1">Antibody </text>
<text top="359" left="39" width="52" height="12" font="1">Description: </text>
<text top="371" left="39" width="2" height="12" font="1"> </text>
<text top="485" left="84" width="61" height="12" font="1">Species Target</text>
<text top="521" left="84" width="90" height="12" font="1">Validation Method #1</text>
<text top="134" left="291" width="25" height="12" font="1">Email:</text>
<text top="134" left="48" width="27" height="12" font="1">Name:</text>
<text top="215" left="48" width="68" height="12" font="1">Antibody Name:</text>
<text top="215" left="300" width="29" height="12" font="1">Target:</text>
<text top="170" left="192" width="15" height="12" font="1">Lab</text>
<text top="249" left="183" width="44" height="12" font="1">Company/</text>
<text top="261" left="183" width="31" height="12" font="1">Source:</text>
<text top="485" left="300" width="53" height="12" font="1">Species Host</text>
<text top="300" left="336" width="50" height="12" font="1">Lot Number</text>
<text top="294" left="39" width="172" height="12" font="1">Catalog Number, database ID, laboratory </text>
<text top="306" left="39" width="2" height="12" font="1"> </text>
<text top="521" left="300" width="90" height="12" font="1">Validation Method #2</text>
<text top="555" left="84" width="50" height="12" font="1">Purification </text>
<text top="567" left="84" width="33" height="12" font="1">Method</text>
<text top="555" left="300" width="48" height="12" font="1">Polyclonal/ </text>
<text top="567" left="300" width="50" height="12" font="1">Monoclonal</text>
<text top="626" left="30" width="58" height="12" font="1">Reference (PI/</text>
<text top="638" left="30" width="49" height="12" font="1">Publication </text>
<text top="650" left="30" width="52" height="12" font="1">Information)</text>
<text top="674" left="28" width="294" height="12" font="1">Please complete the following for antibodies to histone modifications: </text>
<text top="687" left="28" width="205" height="11" font="2">if your specifications are not listed in the drop-down box,  </text>
<text top="697" left="28" width="155" height="11" font="2">please write-in the appropriate information</text>
<text top="728" left="30" width="59" height="12" font="1">Histone Name</text>
<text top="728" left="156" width="52" height="12" font="1">AA modified</text>
<text top="728" left="327" width="48" height="12" font="1">AA Position</text>
<text top="728" left="444" width="53" height="12" font="1">Modification</text>
<text top="419" left="39" width="29" height="12" font="1">Target </text>
<text top="431" left="39" width="52" height="12" font="1">Description: </text>
<text top="443" left="39" width="2" height="12" font="1"> </text>
<text top="599" left="165" width="51" height="12" font="1">Vendor URL:</text>
<text top="77" left="138" width="53" height="12" font="1">Mar 21, 2011</text>
<text top="347" left="94" width="439" height="12" font="1">Mouse monoclonal [4H8] to RNA polymerase II CTD repeat YSPTSPS synthetic peptide (human); sequence </text>
<text top="359" left="94" width="381" height="12" font="1">repeated multiple times in C-terminal domain of RNA pol II largest subunit; recognizes both </text>
<text top="371" left="94" width="190" height="12" font="1">unphosphorylated and phosphorylated forms</text>
<text top="485" left="150" width="31" height="12" font="1">Human</text>
<text top="521" left="178" width="53" height="12" font="2">Western Blot</text>
<text top="134" left="326" width="102" height="12" font="1">fpauli@hudsonalpha.org</text>
<text top="134" left="83" width="35" height="12" font="1">Flo Pauli</text>
<text top="215" left="121" width="280" height="12" font="1">RNA polymerase II CTD repeat YSPTSPS antibody [4H8] - ChIP Grade</text>
<text top="215" left="339" width="22" height="12" font="1">POL2</text>
<text top="170" left="230" width="25" height="12" font="1">Myers</text>
<text top="255" left="239" width="32" height="12" font="1">ABCAM</text>
<text top="485" left="361" width="28" height="12" font="1">Mouse</text>
<text top="300" left="395" width="66" height="12" font="1">648628, 647708</text>
<text top="300" left="215" width="31" height="12" font="1">ab5408</text>
<text top="521" left="395" width="54" height="12" font="2">IP-Mass Spec</text>
<text top="561" left="356" width="50" height="12" font="2">Monoclonal</text>
<text top="425" left="94" width="286" height="12" font="1">Polymerase (RNA) II (DNA directed) polypeptide A, 220kDa; ~217kDa </text>
<text top="437" left="94" width="75" height="12" font="1">Entrez Gene: 5430</text>
<text top="599" left="238" width="184" height="12" font="1">http://www.abcam.com/RNA-polymerase-II-</text>
<text top="611" left="238" width="172" height="12" font="1">CTD-repeat-YSPTSPS-antibody-4H8-ChIP-</text>
<text top="623" left="238" width="81" height="12" font="1">Grade-ab5408.html</text>
</page>
<page number="2" position="absolute" top="0" left="0" height="792" width="612">
<text top="146" left="52" width="57" height="12" font="1">Validation #1 </text>
<text top="158" left="52" width="34" height="12" font="1">Analysis</text>
<text top="661" left="50" width="143" height="12" font="1">Insert Validation Image (click here)</text>
<text top="86" left="125" width="95" height="12" font="1">Western blot protocol: </text>
<text top="98" left="125" width="428" height="12" font="1">Whole cell lysate was immunoprecipitated using primary antibody, and the IP fraction was loaded on a </text>
<text top="110" left="125" width="422" height="12" font="1">12% acrylamide gel and separated with a Bio-Rad PROTEAN II xi system. After separation, the samples </text>
<text top="122" left="125" width="422" height="12" font="1">were transferred to a nitrocellulose membrane with an Invitrogen iBlot system.  Blotting with primary </text>
<text top="134" left="125" width="422" height="12" font="1">(same as that used for IP) and secondary HRP-conjugated antibodies was performed on an Invitrogen </text>
<text top="146" left="125" width="414" height="12" font="1">BenchPro 4100 system. Visualization was achieved using SuperSignal West Femto solution (Thermo </text>
<text top="158" left="125" width="47" height="12" font="1">Scientific).  </text>
<text top="170" left="125" width="2" height="12" font="1"> </text>
<text top="182" left="125" width="172" height="12" font="1">Results: Band of expected size visualized. </text>
<text top="194" left="125" width="2" height="12" font="1"> </text>
<text top="206" left="125" width="412" height="12" font="1">Figure legend: IP-western with ab5408 in nuclear extract (NE) of K562, GM12878, HepG2, and HeLa; </text>
<text top="218" left="125" width="173" height="12" font="1">PM=protein marker. XX band is indicated.</text>
</page>
<page number="3" position="absolute" top="0" left="0" height="792" width="612">
<text top="159" left="57" width="57" height="12" font="1">Validation #2 </text>
<text top="171" left="57" width="34" height="12" font="1">Analysis</text>
<text top="643" left="54" width="145" height="12" font="1">Insert Validation Image (Click here)</text>
<text top="99" left="130" width="144" height="12" font="1">IP followed by mass spectrometry: </text>
<text top="111" left="130" width="419" height="12" font="1">Briefly, K562 whole cell lysates were immunoprecipitated using primary antibody, and the IP fraction </text>
<text top="123" left="130" width="402" height="12" font="1">was loaded on a 12% acrylamide gel and separated with a Bio-Rad PROTEAN II xi system. Gel was </text>
<text top="135" left="130" width="420" height="12" font="1">stained with Coomassie Blue in order to visualize marker bands. A gel fragment corresponding to the </text>
<text top="147" left="130" width="422" height="12" font="1">band indicated above in the western blot image was excised and sent to the University of Alabama at </text>
<text top="159" left="130" width="421" height="12" font="1">Birmingham Cancer Center Mass Spectrometry/Proteomics Shared Facility. There the sample was run </text>
<text top="171" left="130" width="407" height="12" font="1">on an LTQ XL Linear Ion Trap Mass Spectrometer by LC-ESI-MS/MS. Peptides were identified using </text>
<text top="183" left="130" width="419" height="12" font="1">SEQUEST tandem mass spectra analysis, with probability based matching at p &lt; 0.05. As per ENCODE </text>
<text top="195" left="130" width="417" height="12" font="1">data standards, all SEQUEST results are attached, including common contaminants. Target protein is </text>
<text top="207" left="130" width="98" height="12" font="1">listed as hits 3a and 3b. </text>
<text top="219" left="130" width="2" height="12" font="1"> </text>
<text top="231" left="130" width="306" height="12" font="1">Results in document &quot;ENCODE_HAIB_Pol2-4H8_03182011_MassSpec.pdf&quot;</text>
<text top="695" left="268" width="68" height="12" font="1">Submit by Email</text>
</page>
</pdf2xml>
